When CXCR4 expression was evaluated using the the Cancer Gene-Expression Miner -bc-GenExMiner v.4.8 tool [40], we observed that its expression was significantly higher in ERα-positive/PR-negative tumors when compared to ERα-positive/PR-positive tumors (P < 0.0001). This evidence concerns the gene PGR and cancer.